Literature DB >> 11082050

ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.

J V Grobelny1, A K Godwin, D Broccoli.   

Abstract

Telomere maintenance is essential for the unlimited proliferative potential of human cells, and hence immortalization. However, a number of tumors, tumor-derived cell lines and in vitro immortalized cell lines have been described that do not express detectable telomerase activity. These lines utilize a mechanism, termed Alternative Lengthening of Telomeres (ALT), to provide telomere maintenance. A subset of the cells in each ALT cell line contain a novel form of the promyelocytic leukemia nuclear body (PML NB) in which telomeric DNA and the telomere binding proteins TRF1 and TRF2 co-localize with the PML protein, termed ALT-associated PML bodies (AA-PBs). In contrast, in non-ALT, telomerase-positive cell lines these telomeric proteins and the PML NB occupy distinct and separate subnuclear domains. PML NBs have been implicated in terminal differentiation, growth suppression and apoptosis. The role, if any, of AA-PBs in telomere maintenance or culture viability in telomerase negative cell lines is unclear, but it has been suggested that cells containing these structures are no longer viable and are marked for eventual death. We utilized a series of human ovarian surface epithelium (HOSE) cell lines that use ALT for telomere maintenance to determine if AA-PBs are indeed markers of cells in these cultures that are no longer cycling. We show that AA-PB positive cells incorporate BrdU and thus are able to carry out DNA replication. In addition, AA-PBs are present in mitotic cells and the frequency of cells containing these structures is increased when cultures are enriched for cells in the G(2)/M phase of the cell cycle suggesting that the formation of AA-PBs is coordinately regulated with the cell cycle. Finally, we demonstrate that the majority of the AA-PB positive cells in the culture are not destined for immediate apoptosis. Taken together the data argue against AA-PBs marking cells destined for death and, instead, raise the possibility that these structures may be actively involved in telomere maintenance via the ALT pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082050     DOI: 10.1242/jcs.113.24.4577

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  44 in total

1.  p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Authors:  Zaineb R Abdul Razak; Robert J Varkonyi; Michelle Kulp-McEliece; Corrado Caslini; Joseph R Testa; Maureen E Murphy; Dominique Broccoli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  PinX1 localizes to telomeres and stabilizes TRF1 at mitosis.

Authors:  Tohru Yonekawa; Shuqun Yang; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

3.  Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.

Authors:  Tania Slatter; Jennifer Gifford-Garner; Anna Wiles; Xin Tan; Yu-Jen Chen; Martin MacFarlane; Michael Sullivan; Janice Royds; Noelyn Hung
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

4.  Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.

Authors:  Irena Draskovic; Nausica Arnoult; Villier Steiner; Silvia Bacchetti; Patrick Lomonte; Arturo Londoño-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

5.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

Review 6.  Unwinding protein complexes in ALTernative telomere maintenance.

Authors:  Saumitri Bhattacharyya; April Sandy; Joanna Groden
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

7.  A role for monoubiquitinated FANCD2 at telomeres in ALT cells.

Authors:  Qiang Fan; Fan Zhang; Briana Barrett; Keqin Ren; Paul R Andreassen
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

8.  Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins.

Authors:  Wei-Qin Jiang; Ze-Huai Zhong; Akira Nguyen; Jeremy D Henson; Christian D Toouli; Antony W Braithwaite; Roger R Reddel
Journal:  J Cell Biol       Date:  2009-05-25       Impact factor: 10.539

9.  The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells.

Authors:  Nassima Temime-Smaali; Lionel Guittat; Assitan Sidibe; Kazuo Shin-ya; Chantal Trentesaux; Jean-François Riou
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.